nafazatrom has been researched along with mopidamol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bemis, KG; Campbell, JB; Matsumoto, K; Merriman, RL; Shackelford, KA; Tanzer, LR | 1 |
| Gastpar, H | 1 |
1 review(s) available for nafazatrom and mopidamol
| Article | Year |
|---|---|
[Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
Topics: Animals; Bencyclane; Cell Adhesion; Cells, Cultured; Dipyridamole; Humans; Lymphocytes; Mice; Mopidamol; Neoplasm Metastasis; Pentoxifylline; Phosphorus Radioisotopes; Platelet Aggregation; Pyrazoles; Pyrazolones; Pyrimidines; Rats | 1983 |
1 other study(ies) available for nafazatrom and mopidamol
| Article | Year |
|---|---|
Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Imidazoles; Lung Neoplasms; Mice; Mopidamol; Naphthalenes; Neoplasm Metastasis; Propylamines; Pyrazoles; Pyrazolones; Random Allocation; Tetrahydronaphthalenes | 1989 |